These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 3097059)

  • 1. Effect of oral glucose administration on plasma growth hormone-releasing hormone (GHRH)-like immunoreactivity levels in normal subjects and patients with idiopathic GH deficiency: evidence that GHRH is released not only from the hypothalamus but also from extrahypothalamic tissue.
    Kashio Y; Chihara K; Kita T; Okimura Y; Sato M; Kadowaki S; Fujita T
    J Clin Endocrinol Metab; 1987 Jan; 64(1):92-7. PubMed ID: 3097059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Idiopathic growth hormone (GH) deficiency, and GH deficiency secondary to hypothalamic germinoma: effect of single and repeated administration of human GH-releasing factor (hGRF) on plasma GH level and endogenous hGRF-like immunoreactivity level in cerebrospinal fluid.
    Chihara K; Kashio Y; Abe H; Minamitani N; Kaji H; Kita T; Fujita T
    J Clin Endocrinol Metab; 1985 Feb; 60(2):269-78. PubMed ID: 3917456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discordance between growth hormone (GH) responses after GH-releasing hormone and insulin hypoglycemia in myotonic dystrophy.
    Okimura Y; Chihara K; Kita T; Kashio Y; Sato M; Kitajima N; Abe H; Takahashi K; Fujita T
    J Clin Endocrinol Metab; 1988 Nov; 67(5):1074-9. PubMed ID: 3141449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retesting young adults with childhood-onset growth hormone (GH) deficiency with GH-releasing-hormone-plus-arginine test.
    Aimaretti G; Baffoni C; Bellone S; Di Vito L; Corneli G; Arvat E; Benso L; Camanni F; Ghigo E
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3693-9. PubMed ID: 11061526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. L-dopa stimulates release of hypothalamic growth hormone-releasing hormone in humans.
    Chihara K; Kashio Y; Kita T; Okimura Y; Kaji H; Abe H; Fujita T
    J Clin Endocrinol Metab; 1986 Mar; 62(3):466-73. PubMed ID: 3080462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of oral administration of L-dopa on the plasma levels of growth hormone-releasing hormone (GHRH) in normal subjects and patients with various endocrine and metabolic diseases].
    Mitsuhashi S; Yamasaki R; Miyazaki S; Saito H; Saito S
    Nihon Naibunpi Gakkai Zasshi; 1987 Aug; 63(8):934-46. PubMed ID: 3123283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatostatin pretreatment enhances growth hormone (GH) responsiveness to GH-releasing hormone: a potential new diagnostic approach to GH deficiency.
    Tzanela M; Guyda H; Van Vliet G; Tannenbaum GS
    J Clin Endocrinol Metab; 1996 Jul; 81(7):2487-94. PubMed ID: 8675565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arginine counteracts the inhibitory effect of recombinant human insulin-like growth factor I on the somatotroph responsiveness to growth hormone-releasing hormone in humans.
    Gianotti L; Maccario M; Lanfranco F; Ramunni J; Di Vito L; Grottoli S; Muller EE; Ghigo E; Arvat E
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3604-8. PubMed ID: 11061509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low dose hexarelin and growth hormone (GH)-releasing hormone as a diagnostic tool for the diagnosis of GH deficiency in adults: comparison with insulin-induced hypoglycemia test.
    Gasperi M; Aimaretti G; Scarcello G; Corneli G; Cosci C; Arvat E; Martino E; Ghigo E
    J Clin Endocrinol Metab; 1999 Aug; 84(8):2633-7. PubMed ID: 10443652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma GH responses to GHRH and insulin-induced hypoglycemia in man.
    Shibasaki T; Hotta M; Masuda A; Imaki T; Obara N; Demura H; Ling N; Shizume K
    J Clin Endocrinol Metab; 1985 Jun; 60(6):1265-7. PubMed ID: 3923025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variable plasma growth hormone (GH)-releasing hormone and GH responses to clonidine, L-dopa, and insulin in normal men.
    Tapanainen P; Knip M; Lautala P; Leppäluoto J
    J Clin Endocrinol Metab; 1988 Oct; 67(4):845-9. PubMed ID: 3138280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulinhypoglycemia but not arginine infusion stimulates circulating plasma growth hormone-releasing hormone (GHRH) concentrations in children.
    Rosskamp R; Schmid G; Klumpp J; Tegeler A
    Horm Metab Res; 1987 Sep; 19(9):434-6. PubMed ID: 3121486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison between insulin-induced hypoglycemia and growth hormone (GH)-releasing hormone + arginine as provocative tests for the diagnosis of GH deficiency in adults.
    Aimaretti G; Corneli G; Razzore P; Bellone S; Baffoni C; Arvat E; Camanni F; Ghigo E
    J Clin Endocrinol Metab; 1998 May; 83(5):1615-8. PubMed ID: 9589665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variations of plasma growth hormone (GH)-releasing factor levels during GH stimulation tests in children.
    Donnadieu M; Evain-Brion D; Tonon MC; Vaudry H; Job JC
    J Clin Endocrinol Metab; 1985 Jun; 60(6):1132-4. PubMed ID: 3923020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Behavior of growth hormone after stimulation with growth hormone releasing hormone (GHRH) in children with disorders of the hypothalamo-hypophyseal axis and girls with Turner syndrome].
    Schmitt K; Schober E; Birnbacher R; Frisch H
    Klin Padiatr; 1996; 208(1):29-34. PubMed ID: 8851324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of pulsatile administration of growth hormone (GH)-releasing hormone on short term linear growth in children with GH deficiency.
    Gelato MC; Ross JL; Malozowski S; Pescovitz OH; Skerda M; Cassorla F; Loriaux DL; Merriam GR
    J Clin Endocrinol Metab; 1985 Sep; 61(3):444-50. PubMed ID: 3926806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth hormone does not inhibit its own secretion during prolonged hypoglycemia in man.
    Barbetti F; Crescenti C; Negri M; Leonetti F; Grossi A; Tamburrano G
    J Clin Endocrinol Metab; 1990 May; 70(5):1371-4. PubMed ID: 2110574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of acute pharmacological reduction of plasma free fatty acids on growth hormone (GH) releasing hormone-induced GH secretion in obese adults with and without hypopituitarism.
    Cordido F; Fernandez T; Martinez T; Peñalva A; Peinó R; Casanueva FF; Dieguez C
    J Clin Endocrinol Metab; 1998 Dec; 83(12):4350-4. PubMed ID: 9851776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of the effects of growth hormone release inhibiting factor enhances plasma growth hormone response to GHRH.
    Shi YF; Fang XD
    Proc Chin Acad Med Sci Peking Union Med Coll; 1989; 4(1):13-8. PubMed ID: 2565570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discordant effects of insulin-hypoglycemia on growth hormone (GH)-releasing hormone-stimulated GH and thyrotropin (TSH)-releasing hormone-stimulated TSH secretion.
    Kelijman M; Frohman LA
    J Clin Endocrinol Metab; 1988 Apr; 66(4):872-5. PubMed ID: 3126217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.